Author/Authors :
Noroozi Alireza نويسنده , Ekhtiari Hamed نويسنده Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran Ekhtiari Hamed , Mokri Azarakhsh نويسنده Psychiatry Department and National Center for Addiction Studies Mokri Azarakhsh , Rezvanfard Mehrnaz نويسنده Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran. , Golesorkhi Mehrshad نويسنده Translational Neuroscience Program, Institute for Cognitive Science Studies, Tehran, Iran. Golesorkhi Mehrshad , Ghassemian Ensieh نويسنده Translational Neuroscience Program, Institute for
Cognitive Science Studies, Tehran, IR Iran , Nasiri Eghbali Aiden نويسنده Rah-e-Roshan Addiction Treatment Center, Karaj, IR
Iran
Abstract :
Background Increasing evidence indicates that opiate users and
methadone maintenance patients (MMPs) are impaired in executive control
tasks and response inhibition behavior compared to healthy individuals;
however, the cognitive functional difference between opiate addicts and
MMPs has not been clarified. Objectives This study employed Go/No-Go
tasks to evaluate the response inhibition behavior in three groups:
active opiate users, stable MMPs and healthy control subjects with
negative urine analysis. Patients and Methods In this study, 45
opiate-dependents (including opium and heroin), 50 successful methadone
maintenance patients (MMPs) and 50 normal controls were recruited. These
three groups were matched in terms of age, gender and education level.
Each subject conducted the six variants of Go/No-Go tasks in a
sequential order, after being given the instructions to respond to
stimulus displayed on the screen by pressing the space bar as quickly as
possible (Go stimuli) and withholding responses to other stimuli (No-Go
stimuli). We used Mann-Whitney nonparametric analysis to compare the
performances of opiate users, MMPs and healthy controls on Go/No-Go task
scores. Results In Go trials, opiate dependents and MMPs showed better
performance than controls with lower omission errors, while in No-Go
trials, opiate users and MMPs committed more errors and revealed poorer
performance than the controls. No significant difference was found
between opiate users and MMPs performance on Go or No-Go trials, and
these groups were significantly faster than controls in response to
targets on Go trials or non-targets on No-Go trials. Conclusions Opiate
users and MMPs showed significant deficits on measures of response
inhibition when compared to the normal participants, while MMPs did not
differ from opiate users in their ability to inhibit their response to
non-targets.